Last $0.0062 USD
Change Today -0.0018 / -22.50%
Volume 4.0K
ARYX On Other Exchanges
Symbol
Exchange
OTC US
As of 1:15 PM 08/20/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Paul Goddard Ph.D.

Chairman and Chief Executive Officer, ARYx Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 33 board members in 6 different organizations across 10 different industries.

See Board Relationships
64--

Background*

Dr. Paul Goddard, Ph.D. has been the Life Science Advisor of CM Capital Investments Pty Ltd since 2002. Dr. Goddard specific expertise in high level commercial strategy and transaction activities, particularly within the biotechnology and pharmaceutical sector. He has served the Chairman of Aryx Therapeutics Inc. since August 2003 and has served Chief Executive Officer since February 2005. Dr. Goddard served as a Consultant of Adolor Corporation from August 2003 to July ...

Read Full Background

Corporate Headquarters*

6300 Dumbarton Circle
Fremont, California 94555

United States

Phone: 510-585-2200
Fax: 510-585-2202

Board Members Memberships*

Former Non-Executive Director
Director
1991-N/A
Former Chairman, Chief Executive Officer and President
1995-N/A
Former Director, Member of Nominating Committee and Member of Audit Committee
1996-N/A
Former Director
1997-Present
Lead Independent Director and Chairman of Compensation Committee
2000-Present
Director and Member of Compensation Committee
2000-2012
Former Chairman
2000-Present
Member of the Board
2001-2005
Former Chairman of the Board
2003-Present
Chairman and Chief Executive Officer
2011-Present
Director

Education*

PhD
University Of London
BS
Queen Elizabeth College, University Of London

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ARYX:US $0.01 USD -0.0018

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Peter M. Hecht Ph.D. Co-Founder, Chief Executive Officer and Director
Ironwood Pharmaceuticals, Inc.
$100.0K
Peter S. Greenleaf Chief Executive Officer, Director, Member of Commercialization Committee and Member of Science & Technology Committee
Sucampo Pharmaceuticals, Inc.
--
Eduardo Javier Sanchiz Yrazu Chief Executive Officer, Member of Management Board, Chief Executive of Corporate Development & Finance, Executive Director and Member of Compliance Committee
Almirall, S.A.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ARYX THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.